The National Inherited Bleeding Disorder Genotyping Laboratory was founded in 2000 to provide molecular diagnostic testing for hemophilia A, hemophilia B, von Willebrand disease, and rare bleeding disorders.


The laboratory is supported by the Association of Hemophilia Clinic Directors of Canada, and by the Queen’s University Department of Pathology and Molecular Medicine. 


Tests may only be ordered by care givers from Canadian hemophilia comprehensive care centers and from clinical genetics clinics across Canada.


The lab is licenced by the Ministry of Health and Long-term Care (MOHLTC) to provide molecular diagnostics for hemophilia A, hemophilia B and von Willebrand disease. 



The lab is accredited by the Institute for Quality Management in Healthcare (IQMH) to ISO 15189. 


Laboratory Director: Dr. David Lillicrap, MD FRCPC


Laboratory Co-Director: Dr. Paula James, MD FRCPC

Medical Laboratory Technologist: Gina Jones, MLT

Medical Genetics Technician: Shawn Tinlin, VT

Senior Clinical Scientist: Dr. Orla Rawley, PhD

Senior Clinical Scientist: Dr. Mackenzie Bowman, PhD